Neuroendocrine Prostate Cancer (NEPC)
Also known as: Neuroendocrine Prostate Cancer
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB18472 | PT217 | 1 | Recruiting | 1 |
DB17256 | Tarlatamab | 1 | Active Not Recruiting | 1 |
DB01234 | Dexamethasone | 1 / 2 | Terminated | 1 |
DB13017 | Rovalpituzumab tesirine | 1 / 2 | Terminated | 1 |
DB05220 | Alisertib | 2 | Completed | 1 |